Oruka Therapeutics, Inc. (ORKA) financials
Oruka Therapeutics, Inc. (ORKA) revenue, EBIT and EBITDA, earnings per share, free cash flow, margins, debt and shareholders equity — annual and quarterly history, charted from SEC filings. No account needed.
In fiscal 2023, Oruka Therapeutics, Inc. reported revenue of $0, net income of -$5M, diluted EPS of -$0.37 and free cash flow of -$5M.
- Revenue (fiscal 2023)
- $0
- Net income (fiscal 2023)
- -$5M
- Diluted EPS (fiscal 2023)
- -$0.37
- Free cash flow (fiscal 2023)
- -$5M
Oruka Therapeutics, Inc. files with the U.S. Securities and Exchange Commission under CIK 0000907654, classified as Pharmaceutical Preparations.
Explore annual and quarterly revenue, earnings, cash flow, margins, debt and equity from SEC filings.